Navigation Links
Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
Date:12/16/2010

ROCKVILLE, Md., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

"The commencement of the first trial in our small molecule platform represents a major milestone for Neuralstem," said Richard Garr, Neuralstem President & CEO. "In addition to our ongoing programs in cell therapeutics, we are now advancing a new class of orally administered drugs that recruit endogenous neural stem cells.  NSI-189 is the first in this class."

"Today's antidepressants are based on a theory of serotonin deficiency," explained Karl Johe, PhD, Chief Scientific Officer and Chairman of Neuralstem's Board of Directors. "A new theory is emerging that chronic stress can lead to hippocampal atrophy and eventually to depression. NSI-189 appears to help the brain repair itself, generating new neurons and protecting against damage. This neurogenic approach is completely novel in the treatment of CNS diseases."

About NS-189

NS-189 is the first in a class of compounds that Neuralstem plans to develop into orally administered drugs.

In mice, NSI-189 both stimulated neurogenesis of the hippocampus and increased its overall volume as well. Additionally, NSI-189 stimulated neurogenesis of human hippocampus-derived neural stem cells in-vitro. Therefore, NSI-189 may reverse the human hippocampal atrophy seen in major
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
2. Neuralstems ALS Trial on Clinical Hold
3. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
4. Neuralstem Announces Issuance of Core Technology Patent in Europe
5. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
6. Accuray Receives FDA Clearance for the CyberKnife® Systems Lung Optimized Treatment
7. Generex Receives New Patent for Buccal Drug Delivery Platform Technologies
8. Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group
9. Tomophase OCTIS(TM) Receives FDA 510(K) Clearance to Market
10. Mylan Receives Approval for Generic Version of Adalat® CC Tablets
11. Medical Messengers AstralJet V4 Receives ONC-ATCB 2011/2012 Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
(Date:5/23/2013)... EDGE, N.J. , May 23, 2013 ... a commercial stage medical device company that develops and ... successful completion of its rights offering.  In addition, the ... March 2011 warrants expired on May 17, 2013. ... of $3.0 million from the rights offering.   A portion ...
(Date:5/23/2013)... 2013  TeamHealth Medical Call Center (THMCC), a ... advice lines, announces its newly formed Clinical Advisory ... administrative leaders, provides clinical expertise to advance THMCC,s ... for hospital clients, physician clients and patients. ... it,s imperative to continuously advance our services and ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4TeamHealth Medical Call Center Forms Clinical Advisory Committee 2
... #313/Expo C -- Varian Medical Systems, Inc.  (NYSE: VAR), will ... fluoroscopy, angiography, cardiology and cone-beam CT imaging at the ... Austria, from March 1- 5, 2012.    ... product improvement," said Stephen Kimmel, vice president of Sales ...
... 29, 2012  Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio) today ... MBA, will be presenting at the Cancer Immunotherapy Conference ... Wednesday, February 29, 2012, in Boston, Massachusetts at the ... (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) Dr. Maida,s ...
Cached Medicine Technology:Varian Medical Systems to Exhibit X-Ray Tubes and Flat Panel Detector Technology Enhancements to Improve Digital Imaging at the ECR Annual Meeting 2NW Bio to Present at the Cancer Immunotherapy Summit 2NW Bio to Present at the Cancer Immunotherapy Summit 3NW Bio to Present at the Cancer Immunotherapy Summit 4
(Date:5/24/2013)... Scott Ryan Tischler of Tischler Brothers ... 200 lbs. of fat in just over a year. ... brother the importance of exercising. Scott also taught Troy ... these 7 rules of healthy eating and having a ... accomplished. , 1.    Find a distraction when a food craving ...
(Date:5/24/2013)... The leading retail brand Short Dresses has recently ... . Now that is quite unbelievable, especially in view of ... since its origin. The retailer has already revealed its wider ... discount offer will be an added bonanza for the frequent ... announce that Short Dresses is to offer different levels of ...
(Date:5/23/2013)... 2013 Magnatag’s new magnetic 365-Day attendance ... reduces vacation conflicts. A Manufacturing Manager from Augusta GA ... now employees and managers can check the board for ... is important to us and the board makes the ... seem harsh but it has made a difference.” ...
(Date:5/23/2013)... May 24, 2013 Sublime Beauty® ... Cellulite Whisperer line, with a 35% discount ... Sale" includes two proprietary products, the Cellulite ... . , Purchasers receive a report "Getting Control ... Gel has a wonderful grapefruit scent," says Kathy ...
(Date:5/23/2013)... High blood glucose is associated with poor outcomes in ... to control hyperglycemia is a common practice in hospitals. ... benefit and even shows harms associated with the use ... (ACP) Clinical Guidelines Committee in a new evidence-based paper ... Medical Quality . , "Clinicians caring for hospitalized patients ...
Breaking Medicine News(10 mins):Health News:short prom dresses Offers Abnormally Low Discount on Its New Collections 2Health News:New Attendance, Vacation and Training Tracker Board Reduces Employee Conflicts and Improves Attendance 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2
... Bill Broadly Outlaws Health Insurance Discrimination; Recognizes,Importance ... ALEXANDRIA, Va., Oct. 3 Mental Health,America ... victory" the approval of a,mental health parity ... against Americans with mental health and substance-use,conditions ...
... More and ... Milk Their Diets, HARRISBURG, Pa., Oct. 3 The ... -- which seem to go in and out,of fashion like shoulder pads and ... 27 percent of Pennsylvania,residents -- remain overweight or obese., A new campaign ...
... Huggies, 30th Anniversary, 30 Real Moms to be Featured in ... National Online ... is,different from generations of the past. Strict definitions of motherhood no,longer ... their terms. To celebrate its 30th anniversary, the Huggies brand,announces the ...
... Bumrungrad International hospital, Bangkok, Thailand, Southeast Asia,s largest private hospital ... launched a unique online service to allow prospective patients to ... what Bumrungrad patients actually paid for over 40 medical procedures ... www.bumrungrad.com/realcost . , ...
... for Comment - October is Breast,Cancer Awareness Month, ... by New York Hospital Queens:, WHO: Karen Karsif, ... Queens, as well as other experts from The Cancer ... and the importance,of early detection. New York Hospital Queens ...
... Foundation (SKTCF) is pleased to announce it is joining,forces ... spread,the message to men and their families about symptoms ... reason is unknown, the,incidence of testicular cancer is growing., ... is to reach men,and their families where they live, ...
Cached Medicine News:Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Message to Pennsylvania Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Pennsylvania Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Generation Huggies Celebrates 30 Years With 30 Moms 2Health News:Generation Huggies Celebrates 30 Years With 30 Moms 3Health News:Bumrungrad International Hospital Makes Treatment Costs Available to Public - Bumrungrad International Offers Free Online Access to Actual Costs of 45 Procedures 2Health News:Bumrungrad International Hospital Makes Treatment Costs Available to Public - Bumrungrad International Offers Free Online Access to Actual Costs of 45 Procedures 3Health News:Understanding Breast Cancer Risks & Management 2Health News:Men's Health Network Welcomes its Newest Member to its Nationwide Team, The Sean Kimerling Testicular Cancer Foundation 2
... The Anti-HCV Low Titer Performance Panel ... from weak to strong positive for antibodies ... is intended for use by manufacturers and ... Comprehensive data from all major test systems ...
... Panel consists of plasma specimens with reactivity ... antibodies to the Hepatitis C Virus., This ... manufacturers and clinical laboratories to evaluate their ... all major test systems are included for ...
... POPmesh is a ... that can be used ... pelvic floor procedures, including ... prolapse. Supple yet strong, ...
Suspend® Tutoplast® Processed Fascia Lata is your naturally safe and strong choice for pelvic floor reconstruction. Suspend comes from a dense matrix of collagen bundles and transverse fasc...
Medicine Products: